Next »
Journal of the Formosan Medical Association
Volume 109, Issue 2
, Pages 91-93
, February 2010
Pyrrole-Imidazole Polyamide: A Novel Gene Silencer and its Potential Use in Drug-eluting Stents
References
- Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk . J Am Coll Cardiol . 2006;48:193–202
- Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus . Eur Heart J . 2007;28:974–979
-
.
Therapeutic potential of oligonucleotide-based therapy in cardiovascular disease
.
Bio Drugs
. 2003;17:383–389
- . Recognition of DNA by designed ligands at subnanomolar concentrations . Nature . 1996;382:559–561
- Synthetic pyrrole-imidazole polyamide inhibits expression of the human transforming growth factor-beta1 gene . J Pharmacol Exp Ther . 2005;315:571–575
- Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-β1 promoter for treatment of progressive renal diseases . J Am Soc Nephrol . 2006;17:422–432
-
Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands
.
Proc Natl Acad Sci USA
. 1998;95:12890–12895
- . Biology of N-methylpyrrole-N-methylimidazole hairpin polyamide . Biol Pharm Bull . 2004;27:468–474
- A pyrrole-imidazole polyamide targeting transforming growth factor-beta1 inhibits restenosis and preserves endothelialization in the injured artery . Cardiovasc Res . 2009;81:797–804
- Novel gene silencer pyrrole-imidazole polyamide targeting lectin-like oxidized low-density lipoprotein receptor-1 attenuates restenosis of the artery after injury . Hypertension . 2008;52:86–92
- . DNAzymes and cardiovascular disease . Br J Pharmacol . 2008;154:741–748
- . Vascular healing after stenting: the role of 17-beta-estradiol in improving re-endothelialization and reducing restenosis . Can J Cardiol . 2005;21:1025–1030
- Network analysis of human in-stent restenosis . Circulation . 2006;114:2644–2654
- . Gene therapy approaches for the prevention of restenosis . Curr Vasc Pharmacol . 2004;2:183–189
- . Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology . Pharmacogenomics . 2006;7:1185–1198
PII: S0929-6646(10)60028-9
doi: 10.1016/S0929-6646(10)60028-9
Next »
Journal of the Formosan Medical Association
Volume 109, Issue 2
, Pages 91-93
, February 2010
